Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

2011965 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 377, Issue 9783, pp. 2103-2114

Field-Weighted Citation Impact: 51.54